Skip to content

An Exploratory Clinical Trial to Evaluate the Efficacy and Safety of a Novel Antibacterial Bone Traction Needle

An Exploratory Clinical Trial to Evaluate the Efficacy and Safety of a Novel Antibacterial Bone Traction Needle

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05735470
Enrollment
10
Registered
2023-02-21
Start date
2022-03-09
Completion date
2023-05-30
Last updated
2023-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Infection

Keywords

external fixation, implant

Brief summary

The goal of this clinical trial is to test in wound infection. The main question it aims to answer is: Whether this antibacterial bone traction needle is safe and has a good effect on wound infection. Participants will be implanted with an antibacterial bone traction needles and the infection grade of wound after surgery will be observed. If there is a comparison group: Researchers will compare the control group without antibacterial ability to see if the experimental group Can effectively inhibit wound infection.

Interventions

DEVICEantibacterial bone traction needles

Whether to use bone traction needles containing antibacterial coatings

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Limb fractures, infections, defects and deformities caused by various congenital or acquired factors, such as multiple fractures of tibia and fibula, infectious bone defects of tibia, knee varus, horseshoe varus foot, etc.; 2. The subject understands the significance of this project, voluntarily acts as the subject and signs the informed consent.

Exclusion criteria

1. The subjects are pregnant or lactating women; 2. Pathological fractures (such as primary or metastatic tumors); 3. The patient is allergic to iodine and its compounds; 4. The patient is allergic to metal implants; 5. Patients with coagulopathy (such as hemophilia, vitamin K deficiency, severe liver disease, etc.); 6. The patient had participated in other clinical trials in the past 3 months; 7. The patient had contraindications to anesthesia and surgery; 8. The patient is currently receiving chemotherapy or radiotherapy, systemic corticosteroid use (continuous use for more than 3 months); 9. The patient had poor compliance and was judged by the researchers to be unable to complete the experiment according to the research plan, such as alcohol addiction, drug abuse, schizophrenia, dementia, and did not provide consent for voluntary participation in the clinical study.

Design outcomes

Primary

MeasureTime frameDescription
Wound healing grading3 monthsThe wound healing grading is evaluated by combining the wound healing grading, Sims grading and VAS grading

Countries

China

Contacts

Primary ContactXiaoqiang Jin, Doctor
jinxq@zju.edu.cn+8615757172193
Backup ContactWangsiyuan Teng, Doctor
+8618357162727

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026